GLUE
Monte Rosa Therapeutics, Inc.CIK 0001826457
Showing the last 10 days.Sign up free for 90 days
Activist & passive stakes
View all GLUE stake filings- PassiveAmendment 2Below 5%Nov 16, 2026Monte Rosa Therapeutics, Inc.Chen Yu4.4% · 3,781,532 shSEC
- PassiveAmendment 1Nov 16, 2026Monte Rosa Therapeutics, Inc.Vestal Point Capital, LP8.4% · 7,130,000 shSEC
- PassiveAmendment 4Nov 16, 2026Monte Rosa Therapeutics, Inc.Bvf Partners L P/Il5% · 4,276,578 shSEC
| Filing | Holder | % Owned | Shares | Filed | SEC filing |
|---|---|---|---|---|---|
PassiveAmendment 2Below 5% | Chen Yu in Monte Rosa Therapeutics, Inc. | 4.4% | 3,781,532 | Nov 16, 2026 | SEC |
PassiveAmendment 1 | Vestal Point Capital, LP in Monte Rosa Therapeutics, Inc. | 8.4% | 7,130,000 | Nov 16, 2026 | SEC |
PassiveAmendment 4 | Bvf Partners L P/Il in Monte Rosa Therapeutics, Inc. | 5% | 4,276,578 | Nov 16, 2026 | SEC |
Earnings
PaidCompany revenue, EPS, net income, and guidance the moment they file, parsed from SEC 8-K earnings releases. Create a free account to get started, then unlock earnings on a paid plan.
- Revenue and adjusted / GAAP EPS per quarter
- GAAP net income with profit and loss at a glance
- Forward EPS guidance when companies provide it